Clinical Trials Directory

Trials / Completed

CompletedNCT04941742

The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)

The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis

Status
Completed
Phase
Study type
Observational
Enrollment
71 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the relationship between fractionated exhaled nitric oxide, peripheral eosinophils, and plasma citrulline and ß-alanine in patients with eosinophilic esophagitis (EoE) compared to those without EoE. The hypothesis is that a combination of elevated fractional exhaled nitric oxide, increased peripheral eosinophils, and elevated plasma citrulline and ß-alanine is associated with active EoE.

Conditions

Timeline

Start date
2020-09-22
Primary completion
2021-12-22
Completion
2021-12-22
First posted
2021-06-28
Last updated
2024-05-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04941742. Inclusion in this directory is not an endorsement.

The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophag (NCT04941742) · Clinical Trials Directory